ADHD Medication Trends in Turkey: 2009-2013

Basit Öğe Kaydı
dc.contributor.authorTurkcapar, Mehmet Hakan
dc.contributor.authorOner, Ozguer
dc.contributor.authorYilmaz, Esra Safak
dc.contributor.authorKaradag, Hasan
dc.contributor.authorVural, Mert
dc.contributor.authorVural, Elif Hilal
dc.contributor.authorAkbulat, Akif
dc.contributor.authorGursoz, Hakki
dc.contributor.authorKerman, Saim
dc.date.accessioned2019-11-09T15:16:46Z
dc.date.available2019-11-09T15:16:46Z
dc.date.issued2017-12
dc.departmentHKÜ, İktisadi, İdari ve Sosyal Bilimler Fakültesi, Psikoloji Bölümüen_US
dc.description.abstractObjective: To investigate the change of ADHD medication prescriptions in Turkey between 2009 and 2013. Method: Consumption data of ADHD medications, immediate release (IR) methylphenidate (MPH; Ritalin), OROS MPH (Concerta), and atomoxetine (Strattera) were obtained from IMS Health database for the November 2008 to October 2013 period. Defined daily dose (DDD) of each drug was calculated according to WHO definitions and time-series analysis was conducted. Results: There was a significant seasonal effect for prescription of all drugs. Annual use of ADHD medications increased 2.18 times for all ADHD medications combined. DDDs per 1,000 population per day for all ADHD medications were 0.28 in 2009, 0.41 in 2010, 0.52 in 2011, and 0.59 in 2012. OROS MPH represented almost 75% of all ADHD medication utilization. Conclusion: As reported from several other countries, ADHD medication use increased in Turkey. Results suggested that over- and underdiagnosis might be seen at the same time.en_US
dc.identifier.citationOner, O., Yilmaz, E. S., Vural, M., Vural, E. H., Akbulat, A., Gursoz, H., Kerman, S., ... Turkcapar, H. (December 01, 2017). ADHD Medication Trends in Turkey: 2009-2013. Journal of Attention Disorders, 21, 14, 1192-1197.en_US
dc.identifier.doi10.1177/1087054714523129
dc.identifier.endpage1197en_US
dc.identifier.issn1087-0547
dc.identifier.issn1557-1246
dc.identifier.issue14en_US
dc.identifier.pmid24554298
dc.identifier.scopus2-s2.0-85032926139
dc.identifier.scopusqualityQ1
dc.identifier.startpage1192en_US
dc.identifier.urihttps://doi.org/10.1177/1087054714523129
dc.identifier.urihttps://hdl.handle.net/20.500.11782/680
dc.identifier.volume21en_US
dc.identifier.wosWOS:000414309400006
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSAGE PUBLICATIONS INCen_US
dc.relation.ispartofJOURNAL OF ATTENTION DISORDERS
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectADHD; atomoxetine; methylphenidate; medication trendsen_US
dc.titleADHD Medication Trends in Turkey: 2009-2013
dc.typeArticle

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
license.txt
Boyut:
1.56 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

İİSBF - P Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu